VCNXVACCINEX, INC.

Nasdaq vaccinex.com


$ 7.63 $ -0.10 (-1.32 %)    

Tuesday, 26-Mar-2024 14:29:52 EDT
QQQ $ 444.88 $ 0.18 (0.04 %)
DIA $ 397.57 $ 4.71 (1.2 %)
SPY $ 523.27 $ 4.36 (0.84 %)
TLT $ 94.66 $ 0.93 (0.99 %)
GLD $ 204.97 $ 0.02 (0.01 %)
$ 7.45
$ 7.65
$ 0.00 x 0
$ 0.00 x 0
$ 7.62 - $ 7.75
$ 7.16 - $ 100.80
24,933
na
2.4M
$ 0.78
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-13-2023 09-30-2023 10-Q
2 08-14-2023 06-30-2023 10-Q
3 05-15-2023 03-31-2023 10-Q
4 03-31-2023 12-31-2022 10-K
5 11-14-2022 09-30-2022 10-Q
6 08-15-2022 06-30-2022 10-Q
7 05-16-2022 03-31-2022 10-Q
8 03-31-2022 12-31-2021 10-K
9 11-08-2021 09-30-2021 10-Q
10 08-16-2021 06-30-2021 10-Q
11 05-17-2021 03-31-2021 10-Q
12 03-31-2021 12-31-2020 10-K
13 11-13-2020 09-30-2020 10-Q
14 08-14-2020 06-30-2020 10-Q
15 05-14-2020 03-31-2020 10-Q
16 03-09-2020 12-31-2019 10-K
17 11-12-2019 09-30-2019 10-Q
18 08-14-2019 06-30-2019 10-Q
19 05-15-2019 03-31-2019 10-Q
20 03-13-2019 12-31-2018 10-K
21 11-13-2018 09-30-2018 10-Q
22 08-14-2018 06-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 vaccinex-announces-it-has-entered-into-eight-new-antibody-discovery-agreements-integrating-use-of-its-proprietary-activmab-platform-to-select-antibodies-against-difficult-to-drug-transmembrane-protein-targets

Eight new antibody discovery agreements incorporate Vaccinex's powerful ActivMAb® Drug Discovery Platform ActivMab® platfor...

 why-vaccinex-vcnx-stock-is-trading-lower

Vaccinex shares are trading lower by 7.1%Thursday morning. The company announced a 1-for-14 reverse stock split.

 vaccinex-inc-announces-1-for-14-reverse-stock-split

Vaccinex, Inc., (NASDAQ:VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodeg...

 why-vaccinex-vcnx-stock-is-popping-off

Vaccinex shares are trading higher by 15% during Wednesday's session. The company announced a private placement transaction...

 vaccinex-announces-pricing-of-37m-private-placement-for-the-sale-of-an-aggregate-3838544-shares-of-common-stock

accinex, Inc. (NASDAQ:VCNX) ("Vaccinex" or the "Company"), a clinical-stage biotechnology company pioneering a ...

 vaccinex-q3-eps-109-up-from-165-yoy

Vaccinex (NASDAQ:VCNX) reported quarterly losses of $(1.09) per share. This is a 33.94 percent increase over losses of $(1.65) ...

 vaccinex-reports-clinical-benefit-in-interim-analyses-from-two-phase-2-studies-of-pepinemab-combination-treatment-at-society-for-immunotherapy-of-cancers-annual-meeting

Vaccinex, Inc. (NASDAQ:VCNX), a clinical-stage biotechnology company, will be reporting novel findings for its lead product, pe...

 vaccinex-reports-effect-of-pepinemab-treatment-on-new-biomarker-of-brain-inflammation-in-neurodegenerative-diseases

Vaccinex, Inc. (NASDAQ:VCNX), a clinical-stage biotechnology company, today reports novel findings for its lead product, pepine...

 on-oct-10-vaccinex-ot-letter-from-nasdaq-listing-staff-stating-that-co-has-not-regained-compliance-with-minimum-bid-price-standard

- SEC Filing

 vaccinex-13g-filing-shows-orin-hirschman-holds-99-passive-stake-in-co-as-of-september-28

- SEC Filing

 why-parazero-technologies-shares-are-trading-higher-by-over-100-here-are-other-stocks-moving-in-mondays-mid-day-session

Gainers ParaZero Technologies Ltd. (NASDAQ: PRZO) shares jumped 106% to $2.3901 after the company announced an Australian re...

 gold-moves-higher-omniq-shares-plunge

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 300 points on Friday. The Dow ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION